RPRX in the 13F filings
Royalty Pharma PLC · CUSIP G7709Q104
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 6 Aug 2026
- Managers listing it
- 36
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 13 listed it in both
- Shares listed
- 78,584,018
- combined, among listed positions
- Reported value
- $4.4bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 21 buyers (opened or added shares) and 17 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +771,536.
Managers listing RPRX in Q2 2026
36 of 36 holders
Largest increases and reductions, by shares
Increases
- T. Rowe Price Associates Incexisting position · 11,193,657 shares now+9,259,396
- Capital World Investorsexisting position · 9,517,337 shares now+1,480,623
- Renaissance Technologies LLCexisting position · 1,935,800 shares now+1,144,863
- Two Sigma Investments LPexisting position · 2,920,163 shares now+668,638
- AQR Capital Management LLCexisting position · 4,305,412 shares now+523,374
Reductions
- Baillie Gifford & Coexisting position · 10,015,578 shares now-6,140,099
- Jane Street Group LLCexisting position · 53,460 shares now-2,346,922
- Citadel Advisors LLCexisting position · 1,354,640 shares now-1,326,429
- Squarepoint Ops LLCexisting position · 326,641 shares now-1,022,875
- Fidelity (FMR LLC)existing position · 24,513,814 shares now-638,428
New positions and exits
New (8)
Exited (2)
- Farallon Capital Management LLCwas $24m
- ExodusPoint Capital Management LPwas $5.9m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 10 | $1.8bn | n.a. | n.a. |
| Q3 2020 | 7 | $1.6bn | n.a. | n.a. |
| Q4 2020 | 5 | $1.9bn | n.a. | n.a. |
| Q1 2021 | 5 | $1.5bn | n.a. | n.a. |
| Q2 2021 | 8 | $1.5bn | n.a. | n.a. |
| Q3 2021 | 6 | $1.4bn | n.a. | n.a. |
| Q4 2021 | 8 | $1.8bn | n.a. | n.a. |
| Q1 2022 | 8 | $1.8bn | n.a. | n.a. |
| Q2 2022 | 10 | $3.2bn | n.a. | n.a. |
| Q3 2022 | 11 | $3.4bn | n.a. | n.a. |
| Q4 2022 | 17 | $3.4bn | n.a. | n.a. |
| Q1 2023 | 14 | $2.9bn | n.a. | n.a. |
| Q2 2023 | 16 | $2.3bn | n.a. | n.a. |
| Q3 2023 | 14 | $1.9bn | n.a. | n.a. |
| Q4 2023 | 13 | $2.1bn | 8 | 6 |
| Q1 2024 | 10 | $2.2bn | 5 | 6 |
| Q2 2024 | 12 | $1.7bn | 7 | 5 |
| Q3 2024 | 10 | $2.0bn | 7 | 4 |
| Q4 2024 | 10 | $1.6bn | 7 | 3 |
| Q1 2025 | 9 | $2.3bn | 4 | 5 |
| Q2 2025 | 9 | $2.4bn | 4 | 5 |
| Q3 2025 | 11 | $1.9bn | 7 | 5 |
| Q4 2025 | 10 | $2.4bn | 17 | 14 |
| Q1 2026 | 15 | $3.1bn | 18 | 16 |
| Q2 2026 | 15 | $3.9bn | 21 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RPRX and LLY →RPRX and JNJ →RPRX and VRTX →Choose a stock to compare with RPRX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RPRX, latest filings →Back to the 13F Explorer →